|
Match
|
Document |
Document Title |
|
|
6544558 |
Pharmaceutical formulations comprised of amoxicillin in combination with clavulanic acid
Syrup formulations comprising water and compacted granulates which are mixture of amoxycillin and clavulanic acid, together with an intra-granular disintegrant.
|
|
|
6544552 |
Method of producing porous tablets with improved dissolution properties
A method of producing a fast-dissolving pharmaceutical delivery device of moderate strength. The delivery device is a fully formed tablet composed of readily available sugars, strength polymers and...
|
|
|
6544550 |
Medicaments for gastrointestinal disorders
The invention relates to the co-administration in human or veterinary medicine of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)me
thyl]-4H-carbazol-4-one or a physiologically...
|
|
|
6544551 |
Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis
The present invention relates to new solid pharmaceutical compositions containing hexadecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis, a process for the...
|
|
|
6544553 |
Dosage forms and methods for oral delivery of progesterone
Provided is an oral dosage form suitable to deliver a combined dosage of progesterone and which upon delivery through the gastrointestinal tract provides a blood concentration of from about 0.1...
|
|
|
6541025 |
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
The present invention is an oral drug delivery system for delivering unpalatable pharmaceuticals, wherein the pharmaceutical delivery system comprises a lipid, dry particles including at least one...
|
|
|
6534086 |
Composition and method for treatment of inflammation and pain in mammals
A composition for treating inflammation and pain in mammals, particularly humans. Effective amounts of a boswellic acid, a curcuminoid, a gingerol, a capsaicinoid, a bioflavonoid, and a vitamin C...
|
|
|
6531151 |
Composition containing hydroxypropylmethylcellulose and/or ethylcellulose as disintegrants and process for producing it
Pharmaceutical composition comprising at least one active ingredient and hydroxypropylmethylcellulose, highly substituted hydroxypropylcellulose, and/or ethylcellulose as disintegrants, in...
|
|
|
6531152 |
Immediate release gastrointestinal drug delivery system
A gastrointestinal delivery system is provided. The system comprises a drug in combination with a swellable core material, the core being surrounded by a water-insoluble or relatively...
|
|
|
6527868 |
Dextrose in powder form and a process for the preparation thereof
The invention relates to a dextrose in powder form, characterised in that it has a dextrose content at least equal to 99%, an α crystalline form content at least equal to 95%, a water content at...
|
|
|
6524618 |
Directly compressible extended-release matrix formulation for metformin hydrochloride
An extended-release matrx formulation capable of being directly compressed into tablets comprising metformin hydrochloride blended with specific excipients. The excipients used in the formulation...
|
|
|
6524617 |
Synergistic filler composition
A synergistic filler composition for making pharmaceutical tablets of sufficient tablet hardness at low compression force, and low friability, to preclude damage to the tablet upon further...
|
|
|
6524621 |
Core formulation
This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g....
|
|
|
6525084 |
Stable pharmaceutical formulation
This invention relates to a novel granulate and a novel oral solid dosage formulation, each comprising an active ingredient and one or more carriers prepared by a novel wet granulation method. This...
|
|
|
6521254 |
Single-dose antihistamine/decongestant formulations for treating rhinitis
Pharmaceutical dosage forms for oral administration of an antihistamine and a decongestant are disclosed. The dosage forms provide an antihistamine in an amount and formulation to exhibit...
|
|
|
6521247 |
Dual iron containing nutritional supplement
The present invention relates to a nutritional supplement which comprises two different iron compounds, namely a rapidly dissolving iron compound and a slowly dissolving iron compound. The tablet...
|
|
|
6517832 |
Formulations and methods for treating chronic migraine
A prophylactic treatment for the human malady clinically described as migraine headache comprising daily administration in unit dosage form of a first formulation which comprises a major amount of...
|
|
|
6514958 |
Stabilized tibolone compositions
A stabilized pharmaceutical dosage unit comprising tibolone, in an amount of from 0.1% to 10% by weight of the dosage unit, and a pharmaceutically acceptable carrier. The dosage unit is contained...
|
|
|
6514529 |
Oxazolidinone tablet formulation
The present invention provides a compressed tablet of an antibacterial oxazolidinone agent which provides high drug load and excellent bioavailability.
|
|
|
6511679 |
Breath freshening comestible product and method of controlling breath malodor
A comestible product which includes inulin, a second component and a divalent zinc or copper. When the comestible product is a tablet, a pressed tablet, a lozenge, a hard candy or a chewy candy,...
|
|
|
6506390 |
Progestogen-anti-progestogen regimens
A contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient a progestogen, or as the...
|
|
|
6506407 |
Colon-specific drug release system
A system for releasing a drug specifically in the colon of the gastrointestinal tract, which comprises a drug (b) coated with an organic acid-soluble polymer material (a), and a saccharide (c)...
|
|
|
6506420 |
Combinations of psyllium and chitosan for synergistic adsorption of triglyceride
A composition and method for minimizing the absorption of triglycerides and fats in the gastrointestinal tract is described. The composition comprises psyllium and chitosan in a ratio range of 2:1...
|
|
|
6500455 |
Tolperison-containing, pharmaceutical preparation for oral administration
A pharmaceutical preparation containing Tolperison or a salt thereof as an active ingredient in the form of a racemic mixture which can be a 50/50/-racemat or a racemat with the perponderant...
|
|
|
6500456 |
Compressed nitroglycerin tablet and its method of manufacture
The present invention is directed to a stable nitroglycerin containing pharmaceutical composition, preferably a tablet which is prepared by direct compression technology. The formulation closely...
|
|
|
6495162 |
Controlled release oral tablet having a unitary core
A controlled release antihyperglycemic tablet that does not contain an expanding polymer and comprising a core containing the antihyperglycemic drug, a semipermeable membrane coating the core and...
|
|
|
6495177 |
Orally dissolvable nutritional supplement
The present invention provides an orally administrable nutritional supplement which is highly palatable, such as a chewable prenatal vitamin/mineral supplement. The supplement is preferably made in...
|
|
|
6491946 |
Pharmaceutical levothyroxine preparation
The invention relates to a pharmaceutical preparation comprising levothyroxine sodium, potassium iodide, microcrystalline cellulose and binding agent, which is free of antioxidants or further...
|
|
|
6491944 |
Method for making spirillicide
A method for making spirillicide includes mixing a chloride hydrargyrum (Hg 2 Cl 2 ) material and a gypsum material and pork into particles, and the particles are then fried into pills. The...
|
|
|
6491945 |
Hydrocodone therapy
A hydrocodone composition, a hydrocodone dosage form, and a method of administering hydrocodone are disclosed and indicated for hydrocodone therapy.
|
|
|
6488964 |
Process for manufacturing coated gabapentin or pregabalin particles
A process for manufacturing coated particles of γ-aminobutyric acid analogue, whose lactam content by weight relative to the weight of γ-aminobutyric acid analogue is less than 0.5% is disclosed....
|
|
|
6488960 |
Corticosteroid formulation
The present invention pertains to a unit dose formulation comprising 0.25 to 2 mg of a corticosteroid. This small dose can be used to treat rheumatoid arthritis, especially if adapted to release at...
|
|
|
6485773 |
Semen taste-enhancement dietary supplement
The present invention is directed towards a powdered dietary supplement formulation consisting essentially of a combination of freeze-dried fruits, vegetables and spices, wherein the formulation is...
|
|
|
6485741 |
Granulate with high content of L-carnitine or an alkanoyl L-carnitine
A granulate is described containing granules of an active ingredient endowed with therapeutic/nutritional activity coated with a granulating/bonding agent, suitable for conversion into a solid...
|
|
|
6485745 |
Solid oral dosage forms of valsartan
The present invention is concerned with solid oral dosage forms of comprising a) an active agent selected from valsartan and optionally HCTZ , and b) Pharmaceutically acceptable additives suitable...
|
|
|
6485744 |
Stabilized cefuroxime axetil
Solid pharmaceutical compositions comprising cefuroxime axetil as active ingredient and a zinc salt as stabilizer.
|
|
|
6485759 |
Botanical combinations for treating AIDS and immune-deficient patients to maintain good health and the process for preparing the same
Botanical Combination therapies for treating AIDS and immune-deficient patients include therapeutically effective doses of five medicinal plants of Thailand. First combination, ayurvedic...
|
|
|
6482434 |
Method for reducing adverse effects of a weight loss regimen
A method for reducing certain effects associated with a negative calorie balance in a human includes the step of administering conjugated linoleic acid to a human in an amount effective to reduce...
|
|
|
6475510 |
Process for manufacturing bite-dispersion tablets
This invention relates to a method for the manufacture of Bite-dispersion tablets which disperse easily and quickly in the oral cavity, after a gentle bite, without the aid of water, and if...
|
|
|
6471991 |
Soft chewable tablets having convexed shaped face surfaces
The present invention relates to a compressed, chewable tablet containing at least one active ingredient, a water-disintegratable, compressible carbohydrate and a binder. These components are dry...
|
|
|
6471969 |
Two-phase preparation
The invention relates to a two-phase preparation for use at differential times and comprising a product A for the first phase and a product B for the second phase which comprise, independently of...
|
|
|
6472439 |
Medicinal plant dry extracts
The present invention relates to orally administerable medicinal plant dry extracts, wherein the non-volatile phase of the extract is bound in a microdisperse form and/or in the form of a semisolid...
|
|
|
6468959 |
Peroral dosage form for peptide containing medicaments, in particular insulin
There is provided a plural dosage form for peptide pharmaceuticals comprising a matrix of gelatin or gelatin derivative having distributed therein the peptide pharmaceutical in particular insulin,...
|
|
|
6465010 |
Means for creating a mass having structural integrity
The present invention relates to a means for creating a mass having structural integrity, including a rapidly disintegratable tablet for administration with or without the use of water. The present...
|
|
|
6465014 |
pH-dependent sustained release, drug-delivery composition
A pH-dependent sustained release, drug delivery composition capable of being formed into tablets or pellets, wherein the release is controlled by a diffusion barrier formed by the interaction of a...
|
|
|
6465009 |
Water soluble polymer-based rapidly dissolving tablets and production processes thereof
The invention provides for novel compressed tablets capable of rapidly disintegrating in aqueous solutions, comprising at least one non-saccharide water soluble polymer, which are free of organic...
|
|
|
6465011 |
Formulations comprising lipid-regulating agents
The present invention is directed to a solid formulation comprising the lipid-regulating agent dispersed in a hydrophilic, amorphous polymer in which said lipid-regulating agent is present as a...
|
|
|
6462022 |
Lisinopril compositions having large-particle DCPD
The present invention relates to a pharmaceutical composition comprising lisinopril and dibasic calcium phosphate dihydrate (DCPD), produced by a process comprising mixing lisinopril and DCPD with...
|
|
|
6455070 |
Composition for treating symptoms of influenza
A composition for relief of symptoms of colds and influenza, containing, by weight, about 80-88% olive leaf extract powder containing oleuropein, about 5-10% neem leaf powder and up to about 8% of...
|
|
|
6455069 |
Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets
The present invention relates to a mixture of a starch and at least one other excipient for tabletting wherein the starch is free-flowing compressible processed starch powder suitable for use both...
|